For the year ending 2025-12-31, RLAY has $621,331K in assets. $54,271K in debts. $84,018K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 84,018 | |||
| Investments | 470,500 | |||
| Prepaid expenses | 17,787 | |||
| Other current assets | 5,974 | |||
| Total current assets | 578,279 | |||
| Property and equipment, net | 1,726 | |||
| Operating lease assets | 39,990 | |||
| Restricted cash | 1,336 | |||
| Intangible asset | 0 | |||
| Total assets | 621,331 | |||
| Accounts payable | 7,705 | |||
| Accrued expenses | 13,645 | |||
| Operating lease liabilities | 3,765 | |||
| Other current liabilities | 463 | |||
| Total current liabilities | 25,578 | |||
| Operating lease liabilities, net of current portion | 28,693 | |||
| Total liabilities | 54,271 | |||
| Common stock, 0.001 par value 300,000,000 shares authorized as of december 31, 2024 and december 31, 2024 173,868,949 and 167,755,715 shares issued and outstanding as of december 31, 2025 and december 31, 2024,respectively | 168 | |||
| Additional paid-in capital | 2,580,928 | |||
| Accumulated other comprehensive loss | 733 | |||
| Accumulated deficit | -2,014,769 | |||
| Total stockholders' equity | 567,060 | |||
| Total liabilities and stockholders' equity | 621,331 | |||
Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics, Inc. (RLAY)